Patent details
EP2513148 Title: ANTI-HER2 ANTIBODIES AND THEIR USES
Basic Information
- Publication number:
- EP2513148
- PCT Application Number:
- PCT/US/2010/060533
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107910366
- PCT Publication Number:
- WO/2011/084496
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-HER2 ANTIBODIES AND THEIR USES
- French Title of Invention:
- ANTICORPS ANTI-HER2 ET LEURS UTILISATIONS
- German Title of Invention:
- ANTI-HER2-ANTIKÖRPER UND IHRE VERWENDUNG
- SPC Number:
Dates
- Filing date:
- 15/12/2010
- Grant date:
- 31/08/2016
- EP Publication Date:
- 31/08/2016
- PCT Publication Date:
- 14/07/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/10/2012
- EP B1 Publication Date:
- 31/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/12/2016
- Expiration date:
- 15/12/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/12/2010
- Name:
- AbbVie Biotherapeutics Inc.
- Address:
- 1500 Seaport Boulevard, Redwood City, CA 94063, United States (US)
Inventor
1
- Name:
- POWERS David B.
- Address:
- United States (US)
2
- Name:
- HARDING Fiona A.
- Address:
- United States (US)
3
- Name:
- DUBRIDGE Robert B.
- Address:
- United States (US)
4
- Name:
- AKAMATSU Yoshiko
- Address:
- United States (US)
Priority
- Priority Number:
- 287155 P
- Priority Date:
- 27/04/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/32;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|